EUVIMEDEUVIMED entdecken
Crossref

Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway

Liyi Zou, Xiaodan Li, Jiansuo Lin, Xuehong Fang, Jie Lin, Lu Zhang, Yan Zhang, Yanwen Liang, Jianwei Ren, Yi Liu, Zunnan Huang iD

Journal of Pharmacy and Pharmacology · 2024

DOI: 10.1093/jpp/rgae008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Liyi Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdo…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The goal of the study is to examine the impact on the malignant biological behaviors of non-small cell lung cancer (NSCLC) of a novel coumarin derivative, ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate (C2F). It also aims to define its underlying mechanism.

Methods

NSCLC cell lines and xenograft nude mice model were conducted to explore the anti-NSCLC effects of C2F in vitro and in vivo. Then, network pharmacology analysis and molecular docking were applied to estimate the possible targets of C2F in NSCLC. Finally, the underlying mechanism of C2F against NSCLC cellular proliferation and tumor development was confirmed using inhibitors or activators of the PI3K/AKT signaling pathway.

Results

Our results showed that C2F was able to inhibit proliferation, migration, and invasion of NSCLC cell lines, induce cell cycle arrest and apoptosis in vitro, and prevent tumor growth in vivo. In addition, the estimated glomerular filtration rate and its downstream pathway (PI3K/AKT/mTOR) were found to be critical for the anti-NSCLC activity of C2F.

Conclusions

C2F inhibits malignant biological behaviors of NSCLC by suppressing EGFR/PI3K/AKT/mTOR signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMiceAnimalsHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMice, NudeMolecular Docking SimulationCell ProliferationSignal TransductionTOR Serine-Threonine KinasesAcetatesCell Line, Tumor

Stichwörter der Autor:innen

EGFRPI3K/AKT/mTORethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetatemalignant biological behaviorsnon-small cell lung cancer

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesAcetates

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, China.
  • Department of Pharmacy, People's Hospital of Longhua District, Shenzhen, Guangdong 518109, China.
  • Department of Physiology, College of Basic Medical Sciences, Guangdong Medical University, Dongguan, Guangdong 523808, China.
  • Department of Pharmacy, Longgang District Maternity and Child Healthcare Hospital of Shenzhen City, Shenzhen, Guangdong 518172, China.
  • Guangdong Provincial Key Laboratory of Research and Development of Natural Drugs, School of Pharmacy, Guangdong Medical University, Zhanjiang, Guangdong 524023, China.
  • Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR 999077, China.

ORCID-Profile: Zunnan Huang

Förderung

  • Guangdong Medical University

Zitieren

APA

Zou, L., Li, X., Lin, J., Fang, X., Lin, J., Zhang, L., Zhang, Y., Liang, Y., Ren, J., Liu, Y., & Huang, Z. (2024). Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae008

Vancouver

Zou L, Li X, Lin J, Fang X, Lin J, Zhang L, et al. Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae008

BibTeX
@article{Zou2024,
  author = {Zou, Liyi and Li, Xiaodan and Lin, Jiansuo and Fang, Xuehong and Lin, Jie and Zhang, Lu and Zhang, Yan and Liang, Yanwen and Ren, Jianwei and Liu, Yi and Huang, Zunnan},
  title = {Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  doi = {10.1093/jpp/rgae008}
}
Kostenlos starten →